Eris Bionxt Private Limited, a active private limited company, was established on 15 June 2020 in Tehsil Goharganj, Madhya Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24299MP2020PTC051505. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹14.31 Cr.
It upholds a compliant status. Employing 116 professional, Its leadership includes Inderjeet Singh Negi (Director), Kaushal Kamlesh Shah (Director), Sachin Shah (Director). Past directors included Darbar Singh Rajput, Mahendra Sharma, Inderjeet Singh Negi. It holds no open charges and ₹73.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Khasra No. 58/1, 58/2 Bishankheda (Obedullaganj) Near Mandideep Industrial Area, Hoshanga, Bad Road,, Tehsil Goharganj, Madhya Pradesh, 464993.
U24299MP2020PTC051505
051505
15 June 2020
₹15.00 Cr
₹14.31 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Eris Bionxt Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Inderjeet Singh Negi | Director | 13 Sep 2024 | Current |
| Kaushal Kamlesh Shah | Director | 13 Sep 2024 | Current |
| Sachin Shah | Director | 13 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 01 Jun 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 19 Apr 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eris Bionxt Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 10.75%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Eris Bionxt had a promoter holding of 18.80% and a public holding of 81.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹735,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Sep 2022 | Others | ₹47.50 Cr | Satisfied |
| 03 May 2021 | Karnataka Bank Ltd. | ₹26.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Eris Bionxt has a workforce of 116 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Eris Bionxt, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eris Bionxt's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sachin Shah was appointed as a Cfo was appointed as a Cfo on 11 Jan 2025 & has been associated with this company since 10 months 16 days . was recorded as a recent event.
The activity Sanad Gajwani was appointed as a Company Secretary was appointed as a Company Secretary on 13 Dec 2024 & has been associated with this company since 11 months 15 days . was completed.
Progress on Kaushal Kamlesh Shah was appointed as a Ceo was appointed as a Ceo on 13 Dec 2024 & has been associated with this company since 11 months 15 days . was documented.
Eris Bionxt Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge registered on 15 Sep 2022 via Charge ID 100610503 with Others was fully satisfied on 20 Sep 2024. was completed.
The activity Inderjeet Singh Negi was appointed as a Director was appointed as a Director on 13 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
The CIN of Eris Bionxt Private Limited is U24299MP2020PTC051505.
Eris Bionxt Private Limited is headquartered at Khasra No. 58/1, 58/2 Bishankheda (Obedullaganj) Near Mandideep Industrial Area, Hoshanga, Bad Road,, Tehsil Goharganj, Madhya Pradesh, 464993.
Eris Bionxt Private Limited was incorporated on 15 June 2020.
The current directors of Eris Bionxt Private Limited are
The primary industry of Eris Bionxt Private Limited is Pharma.
Eris Bionxt Private Limited is unlisted.
The authorized capital of Eris Bionxt Private Limited is ₹15.00 Cr, and the paid-up capital is ₹14.31 Cr.
The compliance status of Eris Bionxt Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX